Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Ho

Showing results (201-210 of 321) with videos related to

Pageof 33
Sort By:
International Journal of Hematology|May 10, 2011
Inflammatory autoimmune neuropathy, presumably induced by bortezomib, in a patient suffering from multiple myelomaStefan Schmitt, H Goldschmidt, B Storch-Hagenlocher, et al.
Leukemia|October 22, 2011
Centrosomal targeting of tyrosine kinase activity does not enhance oncogenicity in chronic myeloproliferative disordersT Bochtler, M Kirsch, B Maier, et al.
Onkologie|June 1, 1986
Mitoxantrone and VP-16 in refractory acute myelogenous leukemiaA D Ho, T Lipp, G Ehninger, et al.
Bone Marrow Transplantation|October 9, 2002
Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantationG Egerer, H Goldschmidt, M Hensel, et al.
Bone Marrow Transplantation|September 27, 2005
Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myelomaS Gerull, M Goerner, A Benner, et al.
Onkologie|February 1, 1988
Deoxycoformycin in therapy of refractory lymphoid neoplasmsA D Ho, J Thaler, R Kuse, et al.
Gene Therapy|May 14, 1998
Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants: preclinical studiesX Li, A Gervaix, D Kang, et al.
Leukemia|March 1, 1990
Monoclonal antibody B-ly7: a sensitive marker for detection of minimal residual disease in hairy cell leukemiaJ Thaler, O Dietze, V Faber, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 1995
Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1M Yu, M C Leavitt, M Maruyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myelomaK Neben, T Moehler, G Egerer, et al.
Pageof 33

Showing results (201-210 of 321) with videos related to

Sort By:
Pageof 33
International Journal of Hematology|May 10, 2011
Inflammatory autoimmune neuropathy, presumably induced by bortezomib, in a patient suffering from multiple myelomaStefan Schmitt, H Goldschmidt, B Storch-Hagenlocher, et al.
Leukemia|October 22, 2011
Centrosomal targeting of tyrosine kinase activity does not enhance oncogenicity in chronic myeloproliferative disordersT Bochtler, M Kirsch, B Maier, et al.
Onkologie|June 1, 1986
Mitoxantrone and VP-16 in refractory acute myelogenous leukemiaA D Ho, T Lipp, G Ehninger, et al.
Bone Marrow Transplantation|October 9, 2002
Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantationG Egerer, H Goldschmidt, M Hensel, et al.
Bone Marrow Transplantation|September 27, 2005
Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myelomaS Gerull, M Goerner, A Benner, et al.
Onkologie|February 1, 1988
Deoxycoformycin in therapy of refractory lymphoid neoplasmsA D Ho, J Thaler, R Kuse, et al.
Gene Therapy|May 14, 1998
Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants: preclinical studiesX Li, A Gervaix, D Kang, et al.
Leukemia|March 1, 1990
Monoclonal antibody B-ly7: a sensitive marker for detection of minimal residual disease in hairy cell leukemiaJ Thaler, O Dietze, V Faber, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 1995
Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1M Yu, M C Leavitt, M Maruyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myelomaK Neben, T Moehler, G Egerer, et al.
Pageof 33